The Realities of Panic Disorder

Clinical trials for treatment of panic disorder (PD) may be more generalizable in clinical practice if exclusion criteria were reconsidered, suggest researchers from Hôpital Louis Mourier, Université Paris Descartes, Université Paris Diderot, and Hôpital Corentin-Celton, all in Paris, France. Their study found overly restrictive eligibility requirements could mean as many as 80% of people with PD are excluded from trials. That raises the question: Can results from such trials be generalized to patients in real life?